xmlns:atom="http://www.w3.org/2005/Atom" xmlns:atom="http://www.w3.org/2005/Atom"

SCHEDULES

SCHEDULE 2U.K.Amendment of the Human Medicines (Amendment etc.) (EU Exit) Regulations 2019

PART 10 U.K.Amendment of Part 11 (amendment of Part 11 (Pharmacovigilance))

125.  In regulation 157 (omission of regulation 197 (EU urgent action procedure))—U.K.

(a)in the heading for “Omission” substitute “ Amendment ”;

(b)for “Omit” substitute “In;

(c)after “regulation 197” insert “, in paragraph (1), after “ class of medicinal products ” insert “ authorised for sale or supply under a UKMA(NI), UKMA(UK), THR(NI), THR(UK) or Article 126a authorisation ””.

Commencement Information

I1Sch. 2 para. 125 in force at 31.12.2020 immediately before IP completion day, see reg. 1